Specifically, the HLA-DPB1*04-restricted S167-180 epitope has been shown to stimulate Tfh differentiation, leading to a sustained and robust response to COVID-19 mRNA vaccines (36). This evidence concerns the gene HLA-DPB1 and COVID-19.